, S y r a c u s e , .~~ The complement system of twenty-four patients with psoriasis was studied in detail. Quantitation of classical pathway components (C4, C3, C3-C9) and the a b i l i t y of the patient's serum to support lysis of antibody-coated target cells and C3-C9 consumption a f t e r incubation with a preformed immune precipitate were either normal or elevated. Alternative pathway evaluation involved quantitation of serum levels of factor B and properdin by radial immunodiffusion; in addition, the ability of the patient's serum to support C3-C9 activation with zymosan and cobra venom factor as well as lysis of unsensitized rabbit erythrocytes was also ascertained. Rabbit CH50 t i t e r s and factor B levels were normal or elevated in 23/24 and 24/24 patients respectively. Abnormally low properdin levels more than 2 standard deviations below the normal mean were seen in 14/24 patients. Mean C3-C9 consumption a f t e r zymosan or cobra venom factor incubation was significantly less than normal (p < .001 and 0.025); in 11/24 sera incubated with zymosan, the extent of C3-C9 activation was more than 2 S.D. below the normal mean. Thus, abnormalities of the complement system are clearly present in patients with psoriasis and seem limited to the alternative pathway. Further, these abnormalities suggest that this pathway may be involved in the genesis of this disorder. Children with clinically inactive SLE and JDMS may have abnormal immune function reflecting underlying defects. ADCC, mediated by Fc receptor bearing c e l l s , may play a role in these diseases by eliminating autoantibody coated cells; it i s abnormal in some adult SLE patients. ADCC and i t s inhibition by prednisolone have not been studied i n children with SLE or JDMS. W e have shown that ADCC i s inhibited by i n vitro prednisolone in healthy adults; the purpose of this study i s to determine if ADCC mediated by peripheral mononuclear c e l l s from children with SLE and JDMS i s inhibited by prednisolone. Chang c e l l s labelled with 51-chromium were used as targets. Neither 100 nor 50 ug/dl prednisolone significantly.decreased ADCC ( 7 2 . w 8 . 8 a t 64:l effector:target (E:T) ratio). 6 of these children had clinically inactive disease. 6 SLE patients studied showed a correlation of ADCC with t o t a l hemolytic complement (r=.62). There was no significant decrease i n ADCC when prednisolone was added to c e l l s from 4 children with DMS (70.354.3 a t 64:l E:T), only 1 of whom had active disease. It is concluded that i n vitro prednisolone inhibits ADCC from normal adults but not 7 of 9 children with SLE or 4 children with DMS. It i s speculated that lack of ADCC response to in vitro prednisolone may reflect altered c e l l subpopulations in children with inactive and active SLE and JDMS. (PMN) incubated with live INF-V consume oxygen, generate superoxide and produce chemiluminescence ( C L ) in the absence of serum. PMN exposed to virus incubated in 10% heated pre-immune human sera (PRE sera), in heated post immune sera (POST sera) or in buffer generated comparable peak CL. When PMN were desialytated by pretreatment with neuraminidase to increase the number of available PMN Fc receptors and the cells incubated with virus opsonized in PREserum, no CL was emitted; When desialytated PMN were incubated with virus opsonized in POST-serum, peak CL was 2 -3 fold above control PMN. When PMN Fc receptors were blocked by pretreating the cells with immune complexes and the c e l l s exposed to virus opsonized in PRE-sera, peak CL was equal to that of control PMN; in contrast, these PMN exposed to virus opsonized in POST sera emitted very l i t t l e CL. ~eukemic'blasts-(LB) obtained a t diagnosis from 6 non-T, non-B, and 2 T-cell patients with ALL were studied for their ability to suppress or enhance the proliferative capacity of normal a1 logeneic eripheral blood lymphocytes (PBL) . LB o r control lymphocytes (~y!, preincubated a t 37OC for 48 hrs with 100 ~g/ml Con-A (Ca) or without Con-A (Co), were treated with mitomycin-C. One hundred thousand Ca-or Co-treated LB or Ly were added to 1 x lo5 PBL and cultured with or without supernatants of preincubated cultures in the presence of phytohemagglutinin, Con-A, and pokeweed mitogen. The response of PBL in the presence of supernatants from LB or Ly was markedly suppressed for a l l stimulations ( P = <.001). However, in the absence of supernatants, 2 patients with non-T, non-B ALL and 1 T-cell ALL suppressed the PBL response for a l l mitogens (Z suppression range 10-73.9; control range 19.3-81 . I ) . One T cell and 4 non-T, non-B ALL showed enhancement (range 11.6-232.0). W e conclude that T-cell factors are bifunctional molecules recognizing the stimulant by one end, selecting the cell type by the other end, leading to suppression or augmentation with their restriction specificity.
Movement of phagocytic c e l l s constitutes a major host defense mechanism. Previous studies from t h i s and other laboratories have demonstrated diminished movement of neonatal F '
M N s and WLs.
Nothing, however, i s known of the ontogeny of PMN and MNL movement. W e now report such studies i n the ovine. Fetuses ranging i n age from 120 t o 150 days (term) were delivered of date bred ewes by Caesarean section. PMNs were obtained from venous blood and chemotaxis was measured by a modified Boyden technique, utilizing 3y cellulose acetate f i l t e r s . Endotoxin activated pooled normal sheep plasma was the chemoattractant. Pulmonary alveolar macrophages (PAM) were obtained from the f i r s t 10-12 cc of tracheobronchial aspirate. P A M were sus ended i n McCoy's medium t o a f i n a l concentration of 1.5 x 10g/ml. Chemotaxis was studied by a modification of the method of Snyderman utilizing 811 nuclepore f i l t e r s . The data showed: 1) Regardless of age a t delivery, PMNs and PAMs failed t o show any chemotaxis. This correlated with marked neutropenia i n the f i r s t blood sample obtained. Bone marrow examination, by contrast, showed normal granulocyte stores. Maternal ovine control W s and PAMs showed normal migration; 2) Following delivery, lamb PMNs developed chemotactic responses within several days. This correlated with r i s e i n the peripheral neutrophil count t o normal adult sheep levels. The absence of chemotactic response i n utero was entirel y unexpected'and suggests a regulatory role = Phagocyte function occurring during gestation and the b i r t h process. Children with clinically inactive SLE and JDMS may have abnormal immune function reflecting underlying defects. ADCC, mediated by Fc receptor bearing c e l l s , may play a role in these diseases by eliminating autoantibody coated cells; it i s abnormal in some adult SLE patients. ADCC and i t s inhibition by prednisolone have not been studied i n children with SLE or JDMS. W e have shown that ADCC i s inhibited by i n vitro prednisolone in healthy adults; the purpose of this study i s to determine if ADCC mediated by peripheral mononuclear c e l l s from children with SLE and JDMS i s inhibited by prednisolone. Chang c e l l s labelled with 51-chromium were used as targets. Neither 100 nor 50 ug/dl prednisolone significantly.decreased ADCC ( 7 2 . w 8 . 8 a t 64:l effector:target (E:T) ratio). 6 of these children had clinically inactive disease. 6 SLE patients studied showed a correlation of ADCC with t o t a l hemolytic complement (r=.62). There was no significant decrease i n ADCC when prednisolone was added to c e l l s from 4 children with DMS (70.354.3 a t 64:l E:T), only 1 of whom had active disease. It is concluded that i n vitro prednisolone inhibits ADCC from normal adults but not 7 of 9 children with SLE or 4 children with DMS. It i s speculated that lack of ADCC response to in vitro prednisolone may reflect altered c e l l subpopulations in children with inactive and active SLE and JDMS. (PMN) incubated with live INF-V consume oxygen, generate superoxide and produce chemiluminescence ( C L ) in the absence of serum. PMN exposed to virus incubated in 10% heated pre-immune human sera (PRE sera), in heated post immune sera (POST sera) or in buffer generated comparable peak CL. When PMN were desialytated by pretreatment with neuraminidase to increase the number of available PMN Fc receptors and the cells incubated with virus opsonized in PREserum, no CL was emitted; When desialytated PMN were incubated with virus opsonized in POST-serum, peak CL was 2 -3 fold above control PMN. When PMN Fc receptors were blocked by pretreating the cells with immune complexes and the c e l l s exposed to virus opsonized in PRE-sera, peak CL was equal to that of control PMN; in contrast, these PMN exposed to virus opsonized in POST sera emitted very l i t t l e CL. Electronmicrographs of PMN incubated with unopsonized virus for 20 min demonstrate intracellular virus particles. Thus, in the absence of specific antibody, INF-V enters the PMN and stimulates CL via PMN s i a l i c acid-associated receptors; in the presence of antibody, INF-V stimulates via Fc recptors. These data suggest a previously unrecognized role for PMN-viral interaction in INF-V infections.
GENERATION OF CONCANAVALIN A (Con-A)-INDUCIBLE SUP-PRESSIVE FACTORS IN ACUTE LYMPHOCYTIC LEUKEMIA (ALL).
948 Nallni Mukhopadhyay and Donald J. ~eukemic'blasts-(LB) obtained a t diagnosis from 6 non-T, non-B, and 2 T-cell patients with ALL were studied for their ability to suppress or enhance the proliferative capacity of normal a1 logeneic eripheral blood lymphocytes (PBL) . LB o r control lymphocytes (~y!, preincubated a t 37OC for 48 hrs with 100 ~g/ml Con-A (Ca) or without Con-A (Co), were treated with mitomycin-C. One hundred thousand Ca-or Co-treated LB or Ly were added to 1 x lo5 PBL and cultured with or without supernatants of preincubated cultures in the presence of phytohemagglutinin, Con-A, and pokeweed mitogen. The response of PBL in the presence of supernatants from LB or Ly was markedly suppressed for a l l stimulations ( P = <.001). However, in the absence of supernatants, 2 patients with non-T, non-B ALL and 1 T-cell ALL suppressed the PBL response for a l l mitogens (Z suppression range 10-73.9; control range 19.3-81 . I ) . One T cell and 4 non-T, non-B ALL showed enhancement (range 11.6-232.0) . W e conclude that T-cell factors are bifunctional molecules recognizing the stimulant by one end, selecting the cell type by the other end, leading to suppression or augmentation with their restriction specificity. U n f r a c t i o n a t e d f i c o l l -h y p a q u e s e p a r a t e d c e l l s (68%), T c e l l s (87%), T c e l l s (43%), T non-gamma c e l l s (97%), T c e l l de-. p f e t e d n o n -a d h e r e n t c e l l s (39%). Of t h e non-T, nona d h e r e n t c e l l s , o n l y t h o s e e x p r e s s i n g t h e r e n t i a t e i n t o plasma c e l l s i s due t o b o t h a n i n t r i n s i c c e l l u l a r d e f e c t and a c t i v e s u p p r e s s -$ 0 y~y e~b g f f~~b 8~v a r i o u s c e l l p o p u l a t i o n s . NIH Grant
